“We continue to receive encouraging news about Covid-19 vaccines and remain cautiously optimistic about the potential for new tools to start to arrive in the coming months. But it was no time for complacency”
“It’s worrying that Pfizer-BioNTech has already struck deals with rich countries for more than a billion doses of its vaccine, leaving less than a quarter of its projected supply for the rest of the world.”
